mobilise and pool savings from a large number of investors, (iii) acquire and process information about enterprises and possible investment projects, thus allocating society's savings to its most productive…
Process analytical technologies had been applied to manufacturing processes for decades. Recently, the US Food and Drug Administration (FDA) had re-defined the phrase and implemented into an initiative focusing…
understanding and process control based on sound science, statistical methods and quality risk management. In an attempt to curb rising development costs and regulatory barriers to innovation and creativity
When an innovative biologic product goes off patent, biopharmaceutical or biotechnological companies may file an application for regulatory approval of biosimilar products. Unlike small molecule drug products…
conducting the installation activities of the internal and external lights. Particularly, an iterative process was established, allowing an in-site rapid correction of the major deficiencies encountered during the…
patient or imaging device. The tools available today have made it possible to innovatively extract information about human body in a convenient and economical fashion. The continuing advances made available ... fact…
Saudi Arabia drug market because of its pricing structure and rapid approval processes. Additionally, private and public are operate under no tax policies. The government supports the regulation ... postdoctoral…
just beginning to enter drug regulatory processes, but within a few decades could comprise a dominant group within the class of innovative pharmaceuticals, the current thinking of government safety
consolidating the efforts of potentially many individuals and consequently speeding up the whole process. LIMSs can save considerable amounts of time and dramatically improve the level of data access ... LIMS, could…
substitutes for original biologics, herein referred to as biosimilars. However, the process of introducing a biosimilar to an innovator product is far more complex than the straightforward process of introducing
innovator product. Unlike the more common small-molecules drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers ... exact…
world. In 1970, Indian Patents Act 1970 was passed which allowed only process patents for new molecules and chemical entities (NCEs). This law opened gates for reverse engineering of medicines ... post 1995) era has…
office provides uniform policies and review processes for the pharmaceutical industry. A generic drug product is one that is comparable to an innovator drug product in dosage form, strength, route ... refers generic…
happened during clinical trials,how drug behaves in the body,how it is manufactured,processed and packaged.ANDA (Abbreviated New Drug Application) do not require preclinical (animal) and clinical (human) studies…
functional foods). Most companies, whether they are major multinational pharmaceutical corporations or small, innovative biotechnology companies, have specialist departments of Regulatory Affairs professionals. The…
fastest growing industries.They contribute a lot to the global market with the advancement of innovation and technology. WHO is reinforcing its role in providing technical support to its member states ... international…
requirements for the approval process of Biosimilar Monoclonal antibodies (mAb) in Regulated and Emerging markets. Biosimilars are biological products that are the replicas of their innovator biopharmaceuticals…
have increased the complexity, unpredictability and intensity of the biopharmaceutical product development and registration process. These challenges likewise reinforce the crucial role of the regulatory team and…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.